Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France.
Front Immunol. 2019 Feb 27;10:250. doi: 10.3389/fimmu.2019.00250. eCollection 2019.
The role of interleukin-1 in the regulation of humoral responses is poorly documented, in contrast to its role in inflammation. Recent findings suggest there is an interleukin-1 axis in the follicular T cell control of B cell responses, involving interleukin-1 receptors (IL-1R1 and IL-1R2) and receptor antagonists (IL-1Ra). Here, we revisit the literature on this topic and conclude that targeting the interleukin-1 pathway should be a valuable therapeutic approach in many diseases involving excessive production of (auto)antibodies, such as autoimmune diseases or allergy.
白细胞介素-1 在体液反应调节中的作用的相关文献记载很少,而其在炎症中的作用却有大量记载。最近的研究结果表明,在滤泡 T 细胞对 B 细胞反应的控制中存在白细胞介素-1 轴,涉及白细胞介素-1 受体(IL-1R1 和 IL-1R2)和受体拮抗剂(IL-1Ra)。在这里,我们重新审视了这一主题的文献,并得出结论,靶向白细胞介素-1 途径应该是许多涉及(自身)抗体过度产生的疾病(如自身免疫性疾病或过敏)的有价值的治疗方法。